Coeliac Disease Clinical Trial
Official title:
Diagnostic Accuracy of a Rapid Technique for the Detection of Intestinal Anti-transglutaminase Antibodies to Enable a Real Time Diagnosis of Celiac Disease
Intestinal Celiac Disease (CD)-antibodies have been described as the best marker to reveal progression toward villous atrophy and could become the diagnostic marker to make prompt diagnosis in the wide clinical spectrum of CD reducing the delay in diagnosis and treatment. The introduction of either anti-endomysial antibodies (EMA) assay or rapid anti-Transglutaminase 2 (TG2) test on supernatant of mechanically lysed biopsy samples in the clinical practice would improve the diagnosis of CD, especially in clinically challenging scenarios. The availability of an accurate test for identifying intestinal CD-antibodies that do not need the culture of intestinal biopsy is less expensive, less time consuming and easier to perform would facilitate the implementation of such technology outside research laboratories, and enable the diagnosis of CD at the end of Gastrointestinal Endoscopy (GIE).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05530070 -
Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies
|
N/A | |
Completed |
NCT04604795 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole
|
Phase 1 | |
Completed |
NCT02965209 -
European Novel Motorized Spiral Endoscopy Trial
|
N/A | |
Completed |
NCT03543540 -
Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease
|
Phase 1 | |
Completed |
NCT03644602 -
Low FODMAPs Diet in Gastrointestinal Disorders
|
N/A | |
Completed |
NCT02675283 -
Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting
|
N/A | |
Completed |
NCT02551289 -
MAgnetic Resonance Imaging in COeliac Disease
|
||
Active, not recruiting |
NCT02442219 -
A Blood Based Diagnostic Test for Coeliac Disease
|
||
Recruiting |
NCT06001177 -
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
|
Phase 2 | |
Completed |
NCT00879749 -
Safety Study of Nexvax2 in Subjects With Coeliac Disease
|
Phase 1 |